Signadori Bio

About Signadori Bio

Signadori Bio is a preclinical biopharmaceutical company focused on developing innovative cell therapy approaches to treat cancer. Its proprietary platform originates from Institut Gustave Roussy, a world-leading oncology center, underscoring its strong scientific pedigree. The company is based in Paris, France, and pursues next‑generation immunotherapy strategies aimed at advancing cancer cure research.